Facebook
X
LinkedIn
Forward| Title | Credit | Series date | Member price |
Non-member price |
|---|---|---|---|---|
|
Meningococcal Prevention: Real Stories, Real Questions, and Real Impact 1.0 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and for non- members. |
|
01/18/2026 to 01/31/2027 | $0.00 | $0.00 |
|
Leucovorin in Autism: An Evidence-Based and Clinically Informed Approach 1.25 NAPNAP Contact Hours of which 1.25 contains pharmacology content. This continuing education activity is offered free for NAPNAP Members and non-members. This presentation synthesizes the evidence on folinic acid in autism, with an emphasis on advances since 2018 within the context of foundational work. We will examine the pathophysiology of cerebral folate deficiency (CFD), clarify genetic contributors (e.g., FOLR1 and folate-pathway variants), and review clinical testing with folate receptor-α autoantibodies and related labs. Practical treatment guidance will cover formulation selection, dosing and titration, monitoring, adverse effects, and pharmacy/compounding and cost considerations. Taught by a clinician with extensive real-world experience, the presentation highlights where the evidence is strongest and how to implement it. Learners will finish with a concise, evidence-based framework for evaluating and managing CFD in autism within standard practice. |
|
11/12/2025 to 11/30/2027 | $0.00 | $0.00 |
|
Influenza 2025-2026: Is Your Pediatric Practice Ready? 1.0 NAPNAP Contact Hour of which 0.75 contain pharmacology content. This continuing education activity is offered free for NAPNAP Members and non-members. As we enter influenza season, pediatric-focused APRNs can increase their knowledge and prepare to counsel families and restore confidence in influenza vaccines. This continuing education presentation will teach providers to balance communication of scientific data and vaccine efficacy with acknowledgment of parental concerns and fears, and help families feel empowered to make the best decisions when it comes to flu prevention. |
|
11/14/2025 to 11/30/2026 | $0.00 | $0.00 |
|
Keeping Current in Atopic Diseases 1.25 NAPNAP Contact Hour of which 1.25 pharmacology content. This continuing education activity is offered as part of the 2025 Pediatric Pharmacology Bundle. This course is a recorded presentation for NAPNAP's 20255 National Conference. The field of Allergy & Immunology continues to expand and incorporate new therapeutics to manage difficult diseases. In 2024, new drugs have been approved that can revolutionize treatment for disease management. Patients will look to their primary care clinicians to be knowledgeable and a resource for these therapeutics. This panel will include three NP experts from food allergy centers at the Children’s Hospital of Philadelphia and University of Texas Southwestern and will discuss biologics, immunotherapy options and non-IgE mediated disease updates for food allergy. NAPNAP’s Asthma and Allergy SIG is pleased to support this session. |
|
08/29/2025 to 08/31/2027 | $0.00 | $0.00 |
|
New Pediatric Antibiotic Prescribing Guidelines 1.00 NAPNAP Contact Hour of which 1.00 pharmacology content. This archived presentation from our 2025 national conference is available only as part of a bundle of pharmacology courses recorded during our 2025 conference in Chicago. Purchase the 2025 Pediatric Pharmacology Bundle and gain access to all five courses. |
|
08/29/2025 to 08/31/2027 | $0.00 | $0.00 |
|
Pharmacologic Management of Cardiac Dysrhythmias 1.25 NAPNAP Contact Hour of which 1.25 pharmacology content. This continuing education activity is offered as part of the 2025 Pediatric Pharmacology Bundle. This course is a recorded presentation for NAPNAP's 20255 National Conference. This presentation will focus on the treatment of common dysrhythmias seen in children, specifically pharmacologic options. We will review both inpatient and outpatient management of various dysrhythmias. |
|
08/29/2025 to 08/31/2027 | $0.00 | $0.00 |
|
2025 Pediatric Pharmacology Update 1.00 NAPNAP Contact Hour of which 1.00 pharmacology content. This continuing education activity is offered as part of the 2025 Pediatric Pharmacology Bundle. This course is a recorded presentation for NAPNAP's 20255 National Conference. A fast-paced update on pediatric prescribing including newly approved or relabeled pediatric medications, and pediatric pharmacology studies in process. Issues that affect pediatric practice including drug shortages, emerging poisoning hazards, and new guidelines will be discussed. |
|
08/29/2025 to 08/31/2027 | $0.00 | $0.00 |
|
Emerging Health Threats in Infants: Congenital Syphilis 0.75 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and non-members. Emerging Health Threats in Infants: Congenital Syphilis |
|
04/08/2025 to 04/30/2027 | $0.00 | $0.00 |
|
Emerging Health Threats in Infants: Perinatal Hepatitis C 0.75 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and non-members. Emerging Health Threats in Infants: Perinatal Hepatitis C. |
|
02/17/2025 to 01/31/2027 | $0.00 | $0.00 |
|
Hidden in Plain Sight: Uncovering Cytomegalovirus (CMV) for the Pediatric NP 0.75 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and non-members. |
|
02/17/2025 to 01/31/2027 | $0.00 | $0.00 |
|
Guidance for Implementing the AAP's 2023 Clinical Practice Guideline for the Evaluation and Treatment of Pediatric Obesity in Primary Care 1.00 NAPNAP Contact Hour. This course is an archived session from NAPNAP's Pediatric Virtual Symposium: 2024 Targeted Topics. The 2023 American Academy of Pediatrics (AAP) CPG for the Evaluation and Treatment of Obesity in Children and Adolescents recommends that children 2-18 years with overweight/obesity be comprehensively evaluated for comorbidities and offered multicomponent, family-based, Intensive Health Behavior and Lifestyle Treatment (IHBLT). This session will focus on the core components of IHBLT and the associated health outcomes. Additionally, participants will learn how to locate recognized Family Healthy Weight Programs and steps to take if there are no local programs. Led by a member of the AAP clinical practice guideline writing team and a member of the NAPNAP Childhood Obesity SIG, this session will help primary care providers assess and build their capacity around IHBLT. |
|
11/15/2024 to 11/30/2026 | $0.00 | $0.00 |
|
RSV 2024-2025 – Is Your Pediatric Practice Ready? 1.0 NAPNAP Contact Hour of which 0.75 contain pharmacology content. This continuing education activity is free to National Association of Pediatric Nurse Practitioners (NAPNAP) members and non-members. This course will provide the necessary education enabling pediatric practice providers and staff to successfully prevent RSV in the most vulnerable pediatric populations using the recommendations to administer the appropriate RSV prevention to infants based on weight, age, pre-term birth history, presence of chronic conditions and race. |
|
10/10/2024 to 10/31/2026 | $0.00 | $0.00 |
|
Increasing Access to Mental Health Care in Massachusetts 0.5 NAPNAP Contact Hour. This continuing education activity is free for NAPNAP Members and non-members. This project is supported by the Health Resources and Services Administration (HRSA) of the US Department of Health and Human Services (HHS) and is specific for those interested in increasing access to mental health care in Massachusetts. |
|
07/19/2024 to 12/31/2026 | $0.00 | $0.00 |
|
Human Trafficking: Raising Awareness to Identify Victims in the Clinical Setting Providers must register for a free PedsCE account, and be logged in to watch the webinar and receive the certificate. This course was created in collaboration with NAPNAP Partners for Vulnerable Youth. This continuing education activity is offered free for NAPNAP members and nonmembers. |
|
10/06/2020 to 08/29/2027 | $0.00 | $0.00 |
|
JPHC CE: Child Maltreatment Consequences: Essentials for Pediatric Nurse Practitioners 1.5 NAPNAP contact hour. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Child maltreatment is a global pediatric healthcare problem of epidemic proportions. Child maltreatment negatively impacts short and long-term physical, mental, and social health outcomes for child victims. It is imperative that PNPs possess an understanding of the consequences related to experiencing child maltreatment and implement evidence-based interventions to foster healing. This continuing education article will discuss the consequences of child maltreatment and suggest implications for PNP practice including anticipatory guidance, screening, and evidence-based interventions using a trauma-informed approach for child victims. J pediatr Health Care. (2026) 40, 617-629. |
|
07/01/2026 to 08/31/2027 | $0.00 | $10.00 |